The EPO, Europe’s Patent Agency, today announced the grant of patent EP 2125029 to Lipocalyx GmbH. The invention of “Construction and Use of Transfection Enhancer Elements” introduces the principle of a hydrophobic shift to the field of delivery solutions for nucleic acids.
Dr. Steffen Panzner, CEO of Lipocalyx, comments: “The grant of EP 2125029 is fundamental to our Viromer® technology. The principle of a hydrophobic shift was inspired by the way viruses get into cells. We will further exploit this invention to build delivery systems that eventually compete or outperform viral vectors.”